^Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B, Seethala R (1995). „Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor”. J Biol Chem. 270 (39): 22661—4. PMID7559383. doi:10.1074/jbc.270.39.22661.
^Murphy KG, Dhillo WS, Bloom SR (2006). „Gut peptides in the regulation of food intake and energy homeostasis”. Endocrine Reviews. 27 (7): 719—27. PMID17077190. doi:10.1210/er.2006-0028.
Parker E, Van Heek M, Stamford A (2002). „Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.”. Eur. J. Pharmacol. 440 (2-3): 173—87. PMID12007534. doi:10.1016/S0014-2999(02)01427-9.
Gerald C; Walker MW; Vaysse PJ; et al. (1995). „Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype.”. J. Biol. Chem. 270 (45): 26758—61. PMID7592910. doi:10.1074/jbc.270.45.26758.CS1 одржавање: Експлицитна употреба et al. (веза)
Lynch JW; Lemos VS; Bucher B; et al. (1994). „A pertussis toxin-insensitive calcium influx mediated by neuropeptide Y2 receptors in a human neuroblastoma cell line.”. J. Biol. Chem. 269 (11): 8226—33. PMID8132547.CS1 одржавање: Експлицитна употреба et al. (веза)
Gehlert DR; Beavers LS; Johnson D; et al. (1996). „Expression cloning of a human brain neuropeptide Y Y2 receptor.”. Mol. Pharmacol. 49 (2): 224—8. PMID8632753.CS1 одржавање: Експлицитна употреба et al. (веза)
Ammar DA; Eadie DM; Wong DJ; et al. (1997). „Characterization of the human type 2 neuropeptide Y receptor gene (NPY2R) and localization to the chromosome 4q region containing the type 1 neuropeptide Y receptor gene.”. Genomics. 38 (3): 392—8. PMID8975716. doi:10.1006/geno.1996.0642.CS1 одржавање: Експлицитна употреба et al. (веза)
Snow BE; Hall RA; Krumins AM; et al. (1998). „GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain.”. J. Biol. Chem. 273 (28): 17749—55. PMID9651375. doi:10.1074/jbc.273.28.17749.CS1 одржавање: Експлицитна употреба et al. (веза)
Caberlotto L; Fuxe K; Rimland JM; et al. (1998). „Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain.”. Neuroscience. 86 (1): 167—78. PMID9692752. doi:10.1016/S0306-4522(98)00039-6.CS1 одржавање: Експлицитна употреба et al. (веза)
Goumain M; Voisin T; Lorinet AM; et al. (2001). „The peptide YY-preferring receptor mediating inhibition of small intestinal secretion is a peripheral Y(2) receptor: pharmacological evidence and molecular cloning.”. Mol. Pharmacol. 60 (1): 124—34. PMID11408607.CS1 одржавање: Експлицитна употреба et al. (веза)
Uddman R; Möller S; Nilsson T; et al. (2003). „Neuropeptide Y Y1 and neuropeptide Y Y2 receptors in human cardiovascular tissues.”. Peptides. 23 (5): 927—34. PMID12084524. doi:10.1016/S0196-9781(02)00003-7.CS1 одржавање: Експлицитна употреба et al. (веза)
„Neuropeptide Y Receptors: Y2”. IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Архивирано из оригинала 03. 03. 2016. г.
